Aristides Capital’s Exelixis EXEL Stock Holding History

Aristides Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-32,700	Closed	-$563K	–	122
2020 Q1	$563K	Buy	+32,700	New	+$598K	0.41%	50

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Aristides Capital's EXEL Position: Q2 2020 in Review

Aristides Capital sold out of Exelixis (EXEL) in Q2 2020, closing a stake of 32,700 shares — an estimated $563K sold.

Aristides Capital first reported a position in EXEL in Q1 2020 and held it in 1 quarter. The position peaked at $563K in Q1 2020. 374 funds tracked by Wall St. Rank hold EXEL as of Q2 2020.

Aristides Capital reported no remaining Exelixis position as of Q2 2020 after selling out during the quarter.
Aristides Capital sold 32,700 Exelixis shares in Q2 2020, an estimated $563K.
Aristides Capital first reported a position in Exelixis in Q1 2020 and held it in 1 quarter.
Aristides Capital's Exelixis position peaked at $563K in Q1 2020.
374 funds tracked by Wall St. Rank held Exelixis as of Q2 2020.

Based on Aristides Capital's 13F filing for Q2 2020, filed 14 Aug 2020.